col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

Springer-Verlag: Clinical Rheumatology
  original article Date Title Authors   All Authors
1 [GO] 2021―Jul―03 Antimalarial drugs-are they beneficial in rheumatic and viral diseases?-considerations in COVID-19 pandemic Bogna Grygiel-Górniak
2 [GO] 2021―Jul―03 Depression and anxiety might not be increased during COVID-19 pandemic in patient with axial spondyloarthritis E. Erpek, D. Solmaz, D. Bayraktar, S. Akar
3 [GO] 2021―Jul―02 A bibliometric analysis of rheumatology and COVID-19 researches Ozge Pasin, Tugce Pasin
4 [GO] 2021―Jun―29 Factors associated with COVID-19 and its outcome in patients with rheumatoid arthritis Aida Malek Mahdavi, Mojtaba Varshochi, Mehrzad Hajialilo, Saeed Dastgiri, Raha Khabbazi, Alireza Khabbazi
5 [GO] 2021―Jun―29 Predictors of hospitalization for COVID-19 in patients with autoimmune rheumatic diseases: results from a community cohort follow-up Rocío-V. Gamboa-Cárdenas, Silvia Barzola-Cerrón, Denisse Toledo-Neira, Cristina Reátegui-Sokolova, Víctor Pimentel-Quiroz, Francisco Zevallos-Miranda, et al. (+2)
6 [GO] 2021―Jun―25 Isolated “puffy hands” following COVID-19: clue to a long-term capillary leakage syndrome? Jacopo Ciaffi, Riccardo Meliconi, Piero Ruscitti, Annamaria Iagnocco, Clodoveo Ferri, Roberto Giacomelli, Francesco Ursini
7 [GO] 2021―Jun―22 Antibody responses after documented COVID-19 disease in patients with autoimmune rheumatic disease Padmanabha Shenoy, Sakir Ahmed, K. C. Shanoj, Veena Shenoy, Deepak Damodaran, Aparna R. Menon, et al. (+3)
8 [GO] 2021―Jun―05 Clinical features and outcomes of 76 patients with COVID-19-related multi-system inflammatory syndrome in children Fatih Haslak, Kenan Barut, Cansu Durak, Ayten Aliyeva, Mehmet Yildiz, Vafa Guliyeva, et al. (+15)
9 [GO] 2021―May―28 Rheumatology and psychiatry: allies in times of COVID-19 Claudia Elera-Fitzcarrald, Jeff Huarcaya-Victoria, Graciela S. Alarcón, Manuel F. Ugarte-Gil
10 [GO] 2021―Apr―29 Coronavirus disease 2019 (COVID-19) vaccination in systemic lupus erythematosus and anti-neutrophil cytoplasmic antibody-associated vasculitis Jackie Sim, Cynthia Ciwei Lim
11 [GO] 2021―Apr―07 Are antiphospholipid antibodies just a common epiphenomenon or are they causative of immune-mediated coagulopathy in COVID-19? Diana Castillo-Martínez, Zaira Torres, Luis M. Amezcua-Guerra, Carlos Pineda
12 [GO] 2021―Mar―22 A practical approach for vaccinations including COVID-19 in autoimmune/autoinflammatory rheumatic diseases: a non-systematic review Mehmet Soy, Gökhan Keser, Pamir Atagunduz, Melek Yalçin Mutlu, Alper Gunduz, Gizem Koybaşi, Cemal Bes
13 [GO] 2021―Mar―19 Correction to: Multisystem inflammatory syndrome in children during the COVID-19 pandemic in Turkey: first report from the Eastern Mediterranean Yasemin Ozsurekci, Sibel Gürlevik, Selman Kesici, Ummusen Kaya Akca, Pembe Derin Oygar, Kubra Aykac, et al. (+13)
14 [GO] 2021―Mar―17 COVID-19 and the clinical course of rheumatic manifestations Sakir Ahmed, Olena Zimba, Armen Yuri Gasparyan
15 [GO] 2021―Mar―06 The impact of SARS-CoV-2 coronavirus infection in patients with systemic lupus erythematosus from a single center in Catalonia Gerard Espinosa, Sergio Prieto-González, Mireia Llevadot, Javier Marco-Hernández, Antonio Martínez-Artuña, Albert Pérez-Isidro, et al. (+2)
16 [GO] 2021―Feb―12 Multisystem inflammatory syndrome in children during the COVID-19 pandemic in Turkey: first report from the Eastern Mediterranean Yasemin Ozsurekci, Sibel Gürlevik, Selman Kesici, Ummusen Kaya Akca, Pembe Derin Oygar, Kubra Aykac, et al. (+12)
17 [GO] 2021―Jan―25 Impact of COVID-19 on rheumatology practice in the UK-a pan-regional rheumatology survey Arvind Nune, Karthikeyan P. Iyengar, Ashar Ahmed, Syed Bilgrami, Hem Raj Sapkota
18 [GO] 2021―Jan―19 Anti-phospholipids antibodies and immune complexes in COVID-19 patients: a putative role in disease course for anti-annexin-V antibodies Antonio Cristiano, Valentina Fortunati, Fabio Cherubini, Sergio Bernardini, Marzia Nuccetelli
19 [GO] 2021―Jan―15 Hydroxychloroquine in the post-COVID-19 era: will this pandemic upset decades of clinical practice? Lucie Pothen, Halil Yildiz, Mathilde Mbouck Samnick, Jean Cyr Yombi
20 [GO] 2021―Jan―11 Superior mesenteric artery syndrome in a patient with rheumatoid arthritis and rheumatoid cachexia during the COVID-19 pandemic Dionicio Ángel Galarza-Delgado, Diana Elsa Flores-Alvarado, Jesús Eduardo Compeán-Villegas
21 [GO] 2021―Jan―11 Tracking awareness for Kawasaki disease in children related to the COVID-19 pandemic Steffen Springer, Artur Strzelecki, Michael Zieger
22 [GO] 2021―Jan―11 COVID-19 vaccination in immunocompromised patients Bhavin Sonani, Fawad Aslam, Amandeep Goyal, Janki Patel, Pankaj Bansal
23 [GO] 2021―Jan―09 Clinical course and outcomes of COVID-19 in rheumatic disease patients: a case cohort study with a diverse population Timothy Arleo, David Tong, Julie Shabto, Ghazala O’Keefe, Arezou Khosroshahi
24 [GO] 2021―Jan―07 COVID-19, rheumatic diseases and immune dysregulation-a perspective Shahna Tariq, Charmaine Van Eeden, Jan Willem Cohen Tervaert, Mohammed S. Osman
25 [GO] 2021―Jan―03 Haemophagocytic syndrome and COVID-19 Soledad Retamozo, Pilar Brito-Zerón, Antoni Sisó-Almirall, Alejandra Flores-Chávez, María-José Soto-Cárdenas, Manuel Ramos-Casals
26 [GO] 2020―Nov―24 Characteristics and evolution of 38 patients with rheumatic diseases and COVID-19 under DMARD therapy Dionicio Ángel Galarza-Delgado, Griselda Serna-Peña, Jesús Eduardo Compeán-Villegas, Jesus Alberto Cardenas-de la Garza, Rita Angélica Pineda-Sic, Iris Jazmín Colunga-Pedraza, et al. (+4)
27 [GO] 2020―Nov―20 COVID-19 in rheumatoid arthritis cases: an Iranian referral center experience Soraya Shadmanfar, Nematollah Jonaidi-Jafari, Ramezan Jafari, Zeynab Rastgar-Moqaddam, Amin Saburi
28 [GO] 2020―Nov―14 COVID-19 and systemic sclerosis: analysis of lifestyle changes during the SARS-CoV-2 pandemic in an Italian single-center cohort Greta Pellegrino, Davide Mohammad Reza Beigi, Carlotta Angelelli, Katia Stefanantoni, Marius Cadar, Silvia Mancuso, et al. (+2)
29 [GO] 2020―Nov―11 Incidence of COVID-19 in patients with rheumatic disease: is prior health education more important than shielding advice during the pandemic? Sarah Kipps, Anindita Paul, Sreekanth Vasireddy
30 [GO] 2020―Oct―31 Population-level interest in anti-rheumatic drugs in the COVID-19 era: insights from Google Trends Sinan Kardeş, Ali Suat Kuzu, Haig Pakhchanian, Rahul Raiker, Mine Karagülle
31 [GO] 2020―Oct―19 Diversifying online rheumatology education options in the era of COVID-19 Sakir Ahmed, Olena Zimba, Armen Yuri Gasparyan
32 [GO] 2020―Oct―16 Challenges, collaboration, and innovation in rheumatology education during the COVID-19 pandemic: leveraging new ways to teach Anisha B Dua, Adam Kilian, Rebecca Grainger, Sarah A Fantus, Zachary S Wallace, Frank Buttgereit, Beth L Jonas
33 [GO] 2020―Oct―04 Biologics in systemic autoimmune diseases during COVID-19 pandemic Narender Annapureddy, Krishna Nalleballe, Sanjeeva Reddy Onteddu, Rohan Sharma, Sen Sheng, Sukanthi Kovvuru, et al. (+2)
34 [GO] 2020―Sep―29 The impact of COVID-19 pandemic on rheumatology practice: a cross-sectional multinational study Nelly Ziadé, Ihsane Hmamouchi, Lina el Kibbi, Nizar Abdulateef, Hussein Halabi, Fatemah Abutiban, et al. (+4)
35 [GO] 2020―Sep―26 Living with arthritis: a “training camp” for coping with stressful events? A survey on resilience of arthritis patients following the COVID-19 pandemic Jacopo Ciaffi, Veronica Brusi, Lucia Lisi, Luana Mancarella, Martina D’Onghia, Elisabetta Quaranta, et al. (+7)
36 [GO] 2020―Sep―26 COVID-19 reinfection or relapse: an intriguing dilemma Manu Madan, Shekhar Kunal
37 [GO] 2020―Sep―24 Clinical impact of COVID-19 on a French population of spondyloarthritis patients Christian Hubert Roux, O. Brocq, F. Gerald, C. Pradier, L. Bailly
38 [GO] 2020―Sep―17 Moving towards online rheumatology education in the era of COVID-19 Sakir Ahmed, Olena Zimba, Armen Yuri Gasparyan
39 [GO] 2020―Sep―08 Managing rheumatic diseases during COVID-19 Amit P. Ladani, Muruga Loganathan, Abhijeet Danve
40 [GO] 2020―Sep―06 Managing rheumatoid arthritis during COVID-19 Rashmi Roongta, Alakendu Ghosh
41 [GO] 2020―Sep―05 Rheumatologists in the COVID-19 era: will there be a new role for the rheumatologist in the care of rheumatic patients? Jorge Morales-Torres, Francisco Javier Aceves-Ávila
42 [GO] 2020―Sep―03 The potential similarities of COVID-19 and autoimmune disease pathogenesis and therapeutic options: new insights approach Sahar Najafi, Elham Rajaei, Rezvan Moallemian, Forough Nokhostin
43 [GO] 2020―Sep―02 African League Against Rheumatism (AFLAR) preliminary recommendations on the management of rheumatic diseases during the COVID-19 pandemic Richard Oluyinka Akintayo, Rachid Bahiri, Yasser El Miedany, Hakeem Olaosebikan, Asgar Ali Kalla, Adewale Olukayode Adebajo, et al. (+19)
44 [GO] 2020―Aug―27 COVID-19 and rheumatic autoimmune systemic diseases: report of a large Italian patients series Clodoveo Ferri, Dilia Giuggioli, Vincenzo Raimondo, Massimo L’Andolina, Antonio Tavoni, Riccardo Cecchetti, et al. (+22)
45 [GO] 2020―Aug―25 High levels of anti-SSA/Ro antibodies in COVID-19 patients with severe respiratory failure: a case-based review Hiroyuki Fujii, Taisuke Tsuji, Tatsuya Yuba, Shunya Tanaka, Yoshifumi Suga, Aosa Matsuyama, et al. (+6)
46 [GO] 2020―Aug―15 Virtual rheumatology appointments during the COVID-19 pandemic: an international survey of perspectives of patients with rheumatic diseases Alyssa Howren, J. Antonio Aviña-Zubieta, Nevena Rebić, Hallie Dau, Louise Gastonguay, Kam Shojania, et al. (+2)
47 [GO] 2020―Jul―28 Successful recovery of recurrence of positive SARS-CoV-2 RNA in COVID-19 patient with systemic lupus erythematosus: a case report and review Feng He, Qingqing Luo, Ming Lei, Lixin Fan, Xinning Shao, Kaiyuan Hu, et al. (+4)
48 [GO] 2020―Jul―27 Determinants of COVID-19 disease severity in patients with underlying rheumatic disease C. Sieiro Santos, C. Moriano Morales, E. Díez Álvarez, C. Álvarez Castro, A. López Robles, T. Perez Sandoval
49 [GO] 2020―Jul―27 Concomitant new diagnosis of systemic lupus erythematosus and COVID-19 with possible antiphospholipid syndrome. Just a coincidence? A case report and review of intertwining pathophysiology Eduardo Mantovani Cardoso, Jasmin Hundal, Dominique Feterman, John Magaldi
50 [GO] 2020―Jul―25 Challenges in delivering rheumatology care during COVID-19 pandemic A. Nune, K. Iyengar, A. Ahmed, H. Sapkota
51 [GO] 2020―Jul―11 Thrombosis in Coronavirus disease 2019 (COVID-19) through the prism of Virchow’s triad Sakir Ahmed, Olena Zimba, Armen Yuri Gasparyan
52 [GO] 2020―Jun―20 Comment on “Colchicine may not be effective in COVID-19 infection; it may even be harmful?” Senol Kobak
53 [GO] 2020―Jun―20 The rationale for the use of colchicine in COVID-19: comments on the letter by Cumhur Cure M et al. Silvia Piantoni, Enrico Colombo, Paolo Airò, Angela Tincani, Antonio Brucato, Franco Franceschini, et al. (+3)
54 [GO] 2020―Jun―19 A complex COVID-19 case with rheumatoid arthritis treated with tocilizumab Shaozhe Cai, Wei Sun, Ming Li, Lingli Dong
55 [GO] 2020―Jun―18 Colchicine as a possible therapeutic option in COVID-19 infection Rafael Parra-Medina, Juan Camilo Sarmiento-Monroy, Adriana Rojas-Villarraga, Edgar Garavito, Giovanni Montealegre-Gómez, Arley Gómez-López
56 [GO] 2020―Jun―17 Impact of anti-rheumatic drugs and steroids on clinical course and prognosis of COVID-19 Carmine Gazzaruso, Nicoletta Carlo Stella, Giuseppe Mariani, Anna Tamburlini, Pietro Garini, Elena Freddi, et al. (+3)
57 [GO] 2020―Jun―17 COVID-19 and Kawasaki disease: an analysis using Google Trends Mrinalini Dey, Sizheng Steven Zhao
58 [GO] 2020―Jun―08 The systemic sclerosis patient in the COVID-19 era: the challenging crossroad between immunosuppression, differential diagnosis and long-term psychological distress Martina Orlandi, Gemma Lepri, Cosimo Bruni, Yukai Wang, Alessandro Bartoloni, Lorenzo Zammarchi, et al. (+4)
59 [GO] 2020―Jun―04 Antiphospholipid antibodies in patient with acute lower member ischemia and pulmonary thromboembolism as a result of infection by SARS-CoV2 C. Sieiro Santos, C. Nogal Arias, C. Moriano Morales, M. Ballesteros Pomar, E. Diez Alvarez, T. Perez Sandoval
60 [GO] 2020―Jun―03 Hydroxychloroquine and chloroquine in COVID-19: should they be used as standard therapy? Sebastián Ibáñez, Oriela Martínez, Francisca Valenzuela, Francisco Silva, Omar Valenzuela
61 [GO] 2020―May―30 Switching to teleconsultation for rheumatology in the wake of the COVID-19 pandemic: feasibility and patient response in India Padmanabha Shenoy, Sakir Ahmed, Aby Paul, Teny Grace Skaria, Joel Joby, Bazil Alias
62 [GO] 2020―May―30 Cytokine storm in COVID-19: pathogenesis and overview of anti-inflammatory agents used in treatment Mehmet Soy, Gökhan Keser, Pamir Atagündüz, Fehmi Tabak, Işık Atagündüz, Servet Kayhan
63 [GO] 2020―May―30 Are patients with rheumatologic diseases on chronic immunosuppressive therapy at lower risk of developing severe symptoms when infected with COVID-19? Kiana Vakil-Gilani, Kenneth O’Rourke
64 [GO] 2020―May―29 COVID-19, chronic inflammatory rheumatic disease and anti-rheumatic treatments Dieu-Donné Ouédraogo, Wendlassida Joelle Stéphanie Tiendrébéogo, Fulgence Kaboré, Honoré Ntsiba
65 [GO] 2020―May―29 Treatment algorithm for COVID-19: a multidisciplinary point of view Felice Galluccio, Tolga Ergonenc, Alvaro Garcia Martos, Abdallah El-Sayed Allam, Maria Pérez-Herrero, Ricardo Aguilar, et al. (+4)
66 [GO] 2020―May―27 Navigating COVID-19 in the developing world Bridget Hodkinson, Prasun Singh, Ayanda Gcelu, Wilson Bautista Molano, Guillermo Pons-Estel, Deshiré Alpízar-Rodríguez
67 [GO] 2020―May―27 Taking care of systemic sclerosis patients during COVID-19 pandemic: rethink the clinical activity Antonina Minniti, Wanda Maglione, Francesca Pignataro, Carmela Cappadona, Roberto Caporali, Nicoletta Del Papa
68 [GO] 2020―May―27 High prevalence of antinuclear antibodies and lupus anticoagulant in patients hospitalized for SARS-CoV2 pneumonia Carmine Gazzaruso, Nicoletta Carlo Stella, Giuseppe Mariani, Carlo Nai, Adriana Coppola, Daniela Naldani, Pietro Gallotti
69 [GO] 2020―May―26 Can COVID-19 cause myalgia with a completely different mechanism? A hypothesis Adem Kucuk, Medine Cumhur Cure, Erkan Cure
70 [GO] 2020―May―25 Corticosteroid treatment in severe COVID-19 pneumonia: two cases and literature review Jinghong Dai, Yali Xiong, Hui Li, Yajun Qian, Ying Xu, Qingqing Xu, et al. (+2)
71 [GO] 2020―May―23 YouTube as a source of information on COVID-19 and rheumatic disease link Burhan Fatih Kocyigit, Mazlum Serdar Akaltun, Ahmet Riza Sahin
72 [GO] 2020―May―14 COVID-19 with rheumatic diseases: a report of 5 cases Chuanfang Cheng, Chuanjing Li, Tao Zhao, Jing Yue, Fang Yang, Yimin Yan, Xiaoan Liu
73 [GO] 2020―May―11 Colchicine may not be effective in COVID-19 infection; it may even be harmful? Medine Cumhur Cure, Adem Kucuk, Erkan Cure
74 [GO] 2020―May―09 Reply to Rheumatologists’ perspective on coronavirus disease 19: is heparin the dark horse for COVID-19? Sakir Ahmed, Prajna Anirvan
75 [GO] 2020―May―09 How should we overcome the threat by the pandemic of 2019-nCoV? Epidemic simulation using the SIRS model Jun Inamo
76 [GO] 2020―Apr―10 Rheumatologists’ perspective on coronavirus disease 19 (COVID-19) and potential therapeutic targets Durga Prasanna Misra, Vikas Agarwal, Armen Yuri Gasparyan, Olena Zimba


[de][en]

Last change 2021―Jun―30 20:09:44 UTC

© Daten-Quadrat 2021       Done in 0.006 sec